Neuroimagen Molecular
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (7)
2024
-
Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis
Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574
2023
-
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 8, pp. 2486-2500
2020
-
Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia
Clinical and Translational Imaging, Vol. 8, Núm. 3, pp. 127-140
2018
-
Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors
Clinical and Translational Oncology, Vol. 20, Núm. 12, pp. 1522-1528
-
Impact on dose and image quality of a software-based scatter correction in mammography
Acta Radiologica, Vol. 59, Núm. 6, pp. 649-656
2015
-
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development
Cancer and Metastasis Reviews, Vol. 34, Núm. 4, pp. 823-842
2009
-
5′-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration
Neurobiology of Disease, Vol. 33, Núm. 2, pp. 164-170